Advertisement

AGE

, Volume 33, Issue 4, pp 555–564 | Cite as

Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts

  • Richard G. A. Faragher
  • Dominic G. A. Burton
  • Patricia Majecha
  • Noel S. Y. Fong
  • Terence Davis
  • Angela Sheerin
  • Elizabeth L. Ostler
Article

Abstract

Resveratrol, trans-3,5,4′-trihydroxystilbene, is a polyphenolic compound which has been reported to mimic the gene expression patterns seen in whole animals undergoing dietary restriction. The mechanism of action of resveratrol remains poorly understood, but modulation of both cellular proliferation and apoptosis has been proposed as important routes by which the molecule may exert its effects. This study reports the effects of both resveratrol and dihydroresveratrol (a primary in vivo metabolite) on the proliferative capacity of human primary fibroblasts. No generalised reduction in the growth fraction was observed when fibroblasts derived from three different tissues were treated with resveratrol at concentrations of 10 μm or less. However, concentrations above 25 μm produced a dose-dependent reduction in proliferation. This loss of the growth fraction was paralleled by an increase in the senescent fraction as determined by staining for senescence associated beta galactosidase and dose recovery studies conducted over a 7-day period. Entry into senescence in response to treatment with resveratrol could be blocked by a 30-min preincubation with the p38 MAP kinase inhibitor SB203580. No effects on proliferation were observed when cells were treated with dihydroresveratrol at concentrations of up to 100 μm.

Keywords

Resveratrol Cellular senescence Ageing MRC5 HCA2 Ek1.Br p38 MAP kinase 

Notes

Acknowledgements

The authors would like to acknowledge the support of Research into Ageing, the Biotechnology and Biological Sciences Research Council, and the EPSRC/BBSRC Strategic Promotion of Ageing Research Capacity (SPARC) network. Also we would like to acknowledge the support of the Glen Foundation for Medical Research in addition to our other research sponsors.

References

  1. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L (2007) Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech Age Dev 128:546–552CrossRefGoogle Scholar
  2. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA (2008) A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS ONE 3:e2264PubMedCrossRefGoogle Scholar
  3. Bellance N, Benard G, Furt F, Begueret H, Smolková K, Passerieux E, Delage JP, Baste JM, Moreau P, Rossignol R (2009) Bioenergetics of lung tumors: alteration of mitochondrial biogenesis and respiratory capacity. Int J Biochem Cell Biol 41:2566–2577PubMedCrossRefGoogle Scholar
  4. Bird J, Ostler EL, Faragher RGA (2003) Can we say that senescent cells cause aging? Exp Gerontol 38(11–12):1319–1326PubMedCrossRefGoogle Scholar
  5. Burton DGA, Sheerin A, Ostler EL, Smith K, Giles PJ, Lowe J, Rhys-Williams W, Kipling DG, Faragher RGA (2007) Cyclin D1 over-expression permits the reproducible detection of senescent human vascular smooth muscle cells. Ann NY Acad Sci 1119:20–31PubMedCrossRefGoogle Scholar
  6. Burton DGA (2009) Cellular senescence, ageing and disease. AGE 31(1):1–9PubMedCrossRefGoogle Scholar
  7. Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A, Tamakloe T, Wang WJ, Song X, Chu WM, Kouttab N, Xu A, Wan Y (2009) SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Med 13(9b):3632–3643PubMedCrossRefGoogle Scholar
  8. Davis T, Baird DM, Haughton MF, Jones CJ, Kipling D (2005) Prevention of accelerated cell aging in Werner syndrome using a p38 mitogen-activated protein kinase inhibitor. J Gerontol Biol Sci Med Sci 60:1386–1393CrossRefGoogle Scholar
  9. Delgado A, Casas J, Llebaria A, Abad JL, Fabrias G (2006) Inhibitors of sphingolipid metabolism enzymes. Biochim Biophys Acta 1758:1957–1977PubMedCrossRefGoogle Scholar
  10. Ferry-Dumazet H, Garnier O, Mamani-Matsuda M, Vercauteren J, Belloc F, Billiard C, Dupouy M, Thiolat D, Kolb JP, Marit G, Reiffers J, Mossalayi MD. (2002) Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 23:1327-33Google Scholar
  11. Funk WD, Wang CK, Shelton DN, Harley CB, Pagon GD, Hoeffler WK (2000) Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model. Exp Cell Res 258:270–278PubMedCrossRefGoogle Scholar
  12. Giovannelli L, Pitozzi V, Jacomelli M, Mulinacci N, Laurenzana A, Dolara P, Mocali A (2010) Protective effects of resveratrol against senescence-associated changes in cultured human fibroblasts. J Gerontol A Biol Sci Med Sci (in press)Google Scholar
  13. Grove GL, Cristofalo VJ (1977) Characterization of the cell cycle of cultured human diploid cells: effects of aging and hydrocortisone. J Cell Physiol 90:415–422PubMedCrossRefGoogle Scholar
  14. Henry C, Vitrac X, Decendit A, Ennamany R, Krisa S, Merillon JM (2005) Cellular uptake and efflux of trans-piceid and its aglycone trans-resveratrol on the apical membrane of human intestinal Caco-2 cells. J Agric Food Chem 53:798–803PubMedCrossRefGoogle Scholar
  15. Herbig U, Ferreira M, Condel L, Carey D, Sedivy JM (2006) Cellular senescence in aging primates. Science 311:1257PubMedCrossRefGoogle Scholar
  16. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191–196PubMedCrossRefGoogle Scholar
  17. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220PubMedCrossRefGoogle Scholar
  18. Kipling D, Jones DL, Smith SK, Giles PJ, Jennert-Burston K, Ibrahim B, Sheerin AN, Evans AJ, Rhys-Willams W, Faragher RG (2009) A transcriptomic analysis of the EK1. Br strain of human fibroblastoid keratocytes: the effects of growth, quiescence and senescence. Exp Eye Res 88(2):277–285PubMedCrossRefGoogle Scholar
  19. Lançon A, Hanet N, Jannin B, Delmas D, Heydel J-M, Lizard G, Chagnon M-C, Artur Y, Latruffe N (2007) Resveratrol in human hepatoma HepG2 Cells: metabolism and inducibility of detoxifying enzymes. Drug Metab Dispos 35:699–703PubMedCrossRefGoogle Scholar
  20. Pascual-Martí MC, Salvador A, Chafer A, Berna A (2001) Supercritical fluid extraction of resveratrol from grape skin of Vitis vinifera and determination by HPLC. Talanta 54:735–740PubMedCrossRefGoogle Scholar
  21. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8(2):157–168PubMedCrossRefGoogle Scholar
  22. Rusin M, Zajkowicz A, Butkiewicz D (2009) Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mech Ageing Dev 30(8):528–537CrossRefGoogle Scholar
  23. Saiko P, Szakmary A, Jaeger W, Szekeres T. (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res. 658:68-94Google Scholar
  24. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnon UM, Albini A, Prosper E (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle of resveratrol. J Biol Chem 276:22586–22594PubMedCrossRefGoogle Scholar
  25. Ulrich S, Huwiler A, Loitsch S, Schmidt H, Stein JM (2007) De novo ceramide biosynthesis is associated with resveratrol-induced inhibition of ornithine decarboxylase activity. Biochem Pharmacol 74:281–289PubMedCrossRefGoogle Scholar
  26. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A. (2006) Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr Biol. 16(3):296-300Google Scholar
  27. Venable ME, Lee JY, Smyth MJ, Bielawska A, Obeid LM (1995) Role of ceramide in cellular senescence. J Biol Chem 270:30701–30708PubMedCrossRefGoogle Scholar
  28. Venable ME, Yin X (2009) Ceramide induces endothelial cell senescence. Cell Biochem Funct 27:547–551PubMedCrossRefGoogle Scholar
  29. Wakeling LA, Ions LJ, Ford D (2009) Could Sirt1-mediated epigenetic effects contribute to the longevity response to dietary restriction and be mimicked by other dietary interventions? Age (Dordr) (in press)Google Scholar
  30. Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–1382PubMedCrossRefGoogle Scholar
  31. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686–689PubMedCrossRefGoogle Scholar
  32. Zdanov S, Debacq-Chainiaux F, Remacle J, Toussaint O (2006) Identification of p38MAPK-dependent genes with changed transcript abundance in H2O2-induced premature senescence of IMR-90 hTERT human fibroblasts. FEBS Lett 580:6455–6463PubMedCrossRefGoogle Scholar

Copyright information

© American Aging Association 2010

Authors and Affiliations

  • Richard G. A. Faragher
    • 1
  • Dominic G. A. Burton
    • 2
  • Patricia Majecha
    • 1
  • Noel S. Y. Fong
    • 1
  • Terence Davis
    • 3
  • Angela Sheerin
    • 1
  • Elizabeth L. Ostler
    • 1
  1. 1.School of Pharmacy and Biomolecular Sciences, Cockcroft BuildingUniversity of BrightonBrightonUK
  2. 2.Division of Gerontology and Geriatric Medicine, Department of MedicineUniversity of Miami, Miller School of MedicineMiamiUSA
  3. 3.Department of Pathology, School of MedicineUniversity of CardiffCardiffUK

Personalised recommendations